CUE icon

Cue Biopharma

37 hedge funds and large institutions have $32.4M invested in Cue Biopharma in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.89M
2 +$466K
3 +$453K
4
Morgan Stanley
Morgan Stanley
New York
+$355K
5
BlackRock
BlackRock
New York
+$240K

Top Sellers

1 -$2.31M
2 -$179K
3 -$166K
4
Goldman Sachs
Goldman Sachs
New York
-$147K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$60.8K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$8.22M
2
$7.72M
3
$5.99M
4
$2.43M
5
$1.73M
6
$1.05M
7
$725K
8
$724K
9
$403K
10
$364K
11
$343K
12
$300K
13
$245K
14
$236K
15
$216K
16
$200K
17
$186K
18
$181K
19
$181K
20
$181K
21
$178K
22
$136K
23
$106K
24
$72K
25
$60K